Nadia Fairbairn

3.9k total citations
118 papers, 2.8k citations indexed

About

Nadia Fairbairn is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Infectious Diseases. According to data from OpenAlex, Nadia Fairbairn has authored 118 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Public Health, Environmental and Occupational Health, 84 papers in Epidemiology and 23 papers in Infectious Diseases. Recurrent topics in Nadia Fairbairn's work include Opioid Use Disorder Treatment (87 papers), HIV, Drug Use, Sexual Risk (69 papers) and Substance Abuse Treatment and Outcomes (29 papers). Nadia Fairbairn is often cited by papers focused on Opioid Use Disorder Treatment (87 papers), HIV, Drug Use, Sexual Risk (69 papers) and Substance Abuse Treatment and Outcomes (29 papers). Nadia Fairbairn collaborates with scholars based in Canada, United States and Ireland. Nadia Fairbairn's co-authors include Evan Wood, Thomas Kerr, Kathy Li, Kanna Hayashi, Seonaid Nolan, Alexander Y. Walley, Phillip O. Coffin, M‐J Milloy, Ján Klimas and Joan Montaner and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Social Science & Medicine.

In The Last Decade

Nadia Fairbairn

110 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nadia Fairbairn Canada 30 1.9k 1.8k 483 428 397 118 2.8k
María J. Bravo Spain 25 1.9k 1.0× 1.8k 1.0× 352 0.7× 336 0.8× 364 0.9× 77 2.9k
Kanna Hayashi Canada 32 3.0k 1.5× 2.2k 1.3× 818 1.7× 662 1.5× 478 1.2× 275 4.1k
Jennifer R. Havens United States 35 2.4k 1.2× 2.1k 1.2× 563 1.2× 947 2.2× 222 0.6× 137 4.3k
Stephen E. Lankenau United States 30 1.3k 0.7× 1.1k 0.6× 207 0.4× 559 1.3× 240 0.6× 100 2.5k
Carolyn Day Australia 32 2.0k 1.0× 1.0k 0.6× 435 0.9× 486 1.1× 196 0.5× 144 2.9k
Luis Sordo Spain 20 1.5k 0.8× 1.7k 1.0× 198 0.4× 356 0.8× 205 0.5× 89 2.7k
Marek C. Chawarski United States 32 2.4k 1.2× 2.5k 1.4× 329 0.7× 554 1.3× 178 0.4× 96 3.8k
Stephen Koester United States 23 1.2k 0.6× 998 0.6× 418 0.9× 427 1.0× 123 0.3× 43 2.0k
Robin A. Pollini United States 31 2.0k 1.0× 1.2k 0.7× 864 1.8× 471 1.1× 178 0.4× 80 2.8k
Lianping Ti Canada 23 1.3k 0.7× 996 0.6× 422 0.9× 267 0.6× 398 1.0× 128 2.0k

Countries citing papers authored by Nadia Fairbairn

Since Specialization
Citations

This map shows the geographic impact of Nadia Fairbairn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadia Fairbairn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadia Fairbairn more than expected).

Fields of papers citing papers by Nadia Fairbairn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadia Fairbairn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadia Fairbairn. The network helps show where Nadia Fairbairn may publish in the future.

Co-authorship network of co-authors of Nadia Fairbairn

This figure shows the co-authorship network connecting the top 25 collaborators of Nadia Fairbairn. A scholar is included among the top collaborators of Nadia Fairbairn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadia Fairbairn. Nadia Fairbairn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bach, Paxton, M. Eugenia Socías, Nadia Fairbairn, et al.. (2025). Trends in stimulant use among patients with opioid use disorder receiving substance use treatment: Findings from a prospective cohort study from 2013 to 2020. Drug and Alcohol Dependence. 273. 112703–112703. 2 indexed citations
3.
4.
5.
Fairbairn, Nadia, et al.. (2024). Characterising methamphetamine/amphetamine use among opioid agonist therapy‐seeking adults with prescription‐type opioid use disorder in Canada. Drug and Alcohol Review. 43(7). 1905–1912. 2 indexed citations
6.
Harris, Miriam, Shira M. Goldenberg, Zishan Cui, et al.. (2023). Association of sex work and social-structural factors with non-fatal overdose among women who use drugs in Vancouver, Canada. International Journal of Drug Policy. 112. 103950–103950. 5 indexed citations
7.
Ofori, Sandra, Omotola O Olasupo, Brittany B. Dennis, et al.. (2023). Cytisine for smoking cessation: A systematic review and meta-analysis. Drug and Alcohol Dependence. 251. 110936–110936. 14 indexed citations
8.
Fairbairn, Nadia, et al.. (2023). Management of γ-hydroxybutyrate intoxication and withdrawal. Canadian Medical Association Journal. 195(22). E786–E786.
9.
Socías, M. Eugenia, Frank Scheuermeyer, Alexis Crabtree, et al.. (2023). Using a cascade of care framework to identify gaps in access to medications for alcohol use disorder in British Columbia, Canada. Addiction. 118(11). 2128–2138. 1 indexed citations
10.
Lake, Stephanie, Jane A. Buxton, Zach Walsh, et al.. (2022). Methadone Dose, Cannabis Use, and Treatment Retention: Findings From a Community-based Sample of People Who Use Unregulated Drugs. Journal of Addiction Medicine. 17(1). e18–e26. 4 indexed citations
11.
Klimas, Ján, Lauren Gorfinkel, Dzmitry Krupchanka, et al.. (2022). Early Career Training in Addiction Medicine: A Qualitative Study with Health Professions Trainees Following a Specialized Training Program in a Canadian Setting. Substance Use & Misuse. 57(14). 2134–2141. 1 indexed citations
12.
Lake, Stephanie, Thomas Kerr, Jane A. Buxton, et al.. (2021). The Cannabis-Dependent Relationship Between Methadone Treatment Dose and Illicit Opioid Use in a Community-Based Cohort of People Who Use Drugs. Cannabis and Cannabinoid Research. 8(1). 155–165. 9 indexed citations
13.
Young, Samantha, Kanna Hayashi, M‐J Milloy, et al.. (2021). Buprenorphine/naloxone associated with a reduced odds of fentanyl exposure among a cohort of people who use drugs in Vancouver, Canada. Drug and Alcohol Dependence. 228. 109006–109006. 4 indexed citations
14.
Ti, Lianping, Nadia Fairbairn, Keith Ahamad, et al.. (2020). Building a hospital‐based addiction medicine consultation service in Vancouver, Canada: the path taken and lessons learned. Addiction. 116(7). 1892–1900. 18 indexed citations
15.
Brar, Rupinder, Kora DeBeck, M‐J Milloy, et al.. (2020). Changes in drug use behaviors coinciding with the emergence of illicit fentanyl among people who use drugs in Vancouver, Canada. The American Journal of Drug and Alcohol Abuse. 46(5). 625–631. 14 indexed citations
16.
Nolan, Seonaid, et al.. (2020). The impact of high-dose opioid prescription on mortality rates among people living with HIV: A retrospective cohort study. International Journal of Drug Policy. 78. 102705–102705. 3 indexed citations
17.
Clark, Jessica, Nadia Fairbairn, Seonaid Nolan, et al.. (2019). Prescription of High-Dose Opioids Among People Living with HIV in British Columbia, Canada. AIDS and Behavior. 23(12). 3331–3339. 1 indexed citations
18.
Knight, Rod, Mohammad Karamouzian, Anna Carson, et al.. (2018). Interventions to address substance use and sexual risk among gay, bisexual and other men who have sex with men who use methamphetamine: A systematic review. Drug and Alcohol Dependence. 194. 410–429. 44 indexed citations
19.
Kerr, Thomas, Niyada Kiatying‐Angsulee, Nadia Fairbairn, et al.. (2010). High rates of midazolam injection among drug users in Bangkok, Thailand. Harm Reduction Journal. 7(1). 7–7. 28 indexed citations
20.
Fairbairn, Nadia, Karyn Kaplan, Kanna Hayashi, et al.. (2009). Reports of evidence planting by police among a community-based sample of injection drug users in Bangkok, Thailand. BMC International Health and Human Rights. 9(1). 24–24. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by María J. Bravo Breakdown of academic impact, for papers by Kanna Hayashi Breakdown of academic impact, for papers by Jennifer R. Havens Breakdown of academic impact, for papers by Stephen E. Lankenau Breakdown of academic impact, for papers by Carolyn Day Breakdown of academic impact, for papers by Luis Sordo Breakdown of academic impact, for papers by Marek C. Chawarski Breakdown of academic impact, for papers by Stephen Koester Breakdown of academic impact, for papers by Robin A. Pollini Breakdown of academic impact, for papers by Lianping Ti
Rankless by CCL
2026